Skip to main content
峆一药业 logo

峆一药业 — Investor Relations & Filings

Ticker · 920478 Beijing Stock Exchange Manufacturing
Open in API
Filings indexed 363 across all filing types
Latest filing 2023-12-11 Governance Information
Country CN China
Listing Beijing Stock Exchange 920478

About 峆一药业

http://www.heryipharma.com/

Anhui Heyi Pharmaceutical Co., Ltd. specializes in the research, development, production, and sales of pharmaceutical intermediates and active pharmaceutical ingredients (APIs). The company focuses on providing high-quality chemical products for various therapeutic areas, including cardiovascular, central nervous system, and anti-infective treatments. With a strong emphasis on technological innovation and quality control, it operates advanced manufacturing facilities that adhere to international standards. Its product portfolio includes key intermediates for widely used medications, supporting both domestic and global pharmaceutical supply chains. The company leverages its expertise in complex chemical synthesis to offer customized solutions and reliable supply to its partners in the life sciences sector.

Recent filings

Filing Released Lang Actions
董事会薪酬与考核委员会议事规则
Governance Information Classification · 95% confidence The document is titled '董事会薪酬与考核委员会议事规则' which translates to 'Board Remuneration and Assessment Committee Rules'. It details the establishment, composition, responsibilities, and procedures of the Board's Remuneration and Assessment Committee. It includes references to company laws, securities laws, and internal governance rules. The document does not contain financial data, earnings, or audit information but focuses on governance practices related to board remuneration and assessment. It is not a report or announcement of financial results or capital changes. Therefore, it fits best under Governance Information (CGR), which covers reports detailing the company's internal rules, board structure, and governance practices. The document length is 3186 characters, which is sufficient for a detailed governance document rather than a brief announcement.
2023-12-11 Chinese
对外担保管理制度
Governance Information Classification · 95% confidence The document is titled as a management system for external guarantees by Anhui Xuyi Pharmaceutical Co., Ltd. It details the company's internal policies, procedures, and governance related to providing external guarantees, including approval processes, risk management, and responsibilities of various company bodies. It is a formal internal governance document rather than a financial report, earnings release, or announcement. There is no indication that this is an announcement of a report publication or a certification. The document is a governance-related policy document issued by the board, focusing on internal rules and procedures. Therefore, it fits best under Governance Information (CGR).
2023-12-11 Chinese
独立董事工作制度
Governance Information Classification · 95% confidence The document is titled '安徽峆一药业股份有限公司独立董事工作制度' which translates to 'Independent Director Work System of Anhui Xuyi Pharmaceutical Co., Ltd.' It details the rules, qualifications, duties, nomination, election, and powers of independent directors within the company. It includes references to legal and regulatory frameworks, board procedures, and governance practices. There is no financial data, earnings information, or report publication announcement. The content is focused on governance structure and internal rules related to the board and independent directors. Therefore, this document fits best under the category of Governance Information (CGR). The document length is 6727 characters, indicating it is a substantive document, not a brief announcement or certification.
2023-12-11 Chinese
利润分配管理制度
Governance Information Classification · 95% confidence The document is titled as a '利润分配管理制度' which translates to 'Profit Distribution Management System' and details the company's policies and procedures for profit distribution, including decision-making processes, conditions for cash dividends, and supervisory mechanisms. It is a detailed internal policy document rather than a financial report or announcement of financial results. The document is not an announcement of voting results, nor is it a report of financial performance or audit. It is also not a regulatory filing or a brief announcement. The content focuses on governance and internal rules related to profit distribution, which aligns with governance information. Therefore, the most appropriate classification is Governance Information (CGR). The document length is 3744 characters, which is substantial for a policy document but not a full financial report.
2023-12-11 Chinese
高级管理人员辞职公告
Board/Management Information Classification · 100% confidence The document is an announcement regarding the resignation of senior management personnel (vice general managers) from the company Anhui Xuyi Pharmaceutical Co., Ltd. It details the resignation dates, shareholdings of the resigning individuals, reasons for resignation, and the impact on the company. There is no financial data, no mention of financial results, no regulatory certifications, or report publications. The content clearly fits the category of announcing changes in senior management.
2023-12-11 Chinese
监事任命公告
Board/Management Information Classification · 100% confidence The document is an announcement regarding the appointment of a new supervisor (监事) at Anhui Xieyi Pharmaceutical Co., Ltd. It details the nomination, approval, and background of the appointed individual, as well as the impact of this appointment on the company. There is no financial data, earnings information, or report publication mentioned. The content focuses on changes in the company's supervisory board, which falls under management or board changes. Therefore, the document fits the category of Board/Management Information (MANG). The document length is short and it is not a report or announcement of a report publication, so it is not RPA or RNS.
2023-12-11 Chinese

Browse filings by year

4 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.